6-Chloronicotine

From WikiMD's WELLNESSPEDIA

(S)-6-Chloronicotine.svg

Chemical compound

6-Chloronicotine
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

6-Chloronicotine is a chemical compound that belongs to the class of nicotine analogs. It is characterized by the substitution of a chlorine atom at the 6-position of the pyridine ring of the nicotine molecule.

Chemical Structure[edit]

The chemical structure of 6-Chloronicotine consists of a pyridine ring bonded to a pyrrolidine ring, similar to nicotine, but with a chlorine atom replacing a hydrogen atom at the 6-position of the pyridine ring. This modification can significantly alter the compound's pharmacological properties.

Synthesis[edit]

The synthesis of 6-Chloronicotine typically involves the chlorination of nicotine or its precursors. Various methods can be employed to achieve this, including direct chlorination or the use of chlorinating agents.

Pharmacology[edit]

6-Chloronicotine interacts with nicotinic acetylcholine receptors (nAChRs) in the central nervous system and peripheral nervous system. The presence of the chlorine atom can affect the binding affinity and efficacy of the compound at these receptors, potentially leading to different biological effects compared to nicotine.

Applications[edit]

Research into 6-Chloronicotine and other nicotine analogs is ongoing, with potential applications in the development of new pharmacotherapies for nicotine addiction, neurodegenerative diseases, and other conditions where nAChRs play a significant role.

Safety and Toxicity[edit]

The safety and toxicity profile of 6-Chloronicotine is not well-documented. As with other nicotine analogs, it is important to handle this compound with care and conduct thorough toxicology studies to understand its potential risks.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.